Gene changes in brain tumors during treatment
Part of Brain & nervous system, Cancer, Genetic & congenital clinical trials.
This study looks at how the genes in glioma (a type of brain tumor) change when you receive treatment. It may help doctors understand why some tumors respond better and could lead to more personalized care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with glioma, a type of brain tumor.
- You are willing to receive treatment and follow the study procedures.
- You do not have other serious infections or immune system problems.
- You do not have other types of cancer outside the brain.
- You do not have severe mental health conditions or uncontrolled diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether brain scans (MRI, PET/CT) can help predict the genetic makeup of glioblastoma, without needing more tissue samples. If you join, you'll get advanced imaging to better understand your tumor and guide future treatment decisions.
This trial tests whether giving bevacizumab (a drug that blocks blood vessel growth) before surgery helps treat newly diagnosed high-grade gliomas. It may be an option for adults who have not had prior anti-angiogenic therapy.
This trial tests a combination of two drugs—sintilimab (an immunotherapy that helps your immune system fight cancer) and low-dose bevacizumab (which blocks blood vessel growth to tumors)—for people whose glioblastoma has returned after standard treatment. The goal is to see if this combo can slow or stop the cancer with fewer side effects.
This study looks for blood test markers that may predict who survives at 6 months after starting bevacizumab for glioblastoma that has come back. It does not aim to cure the cancer by itself, but to improve doctors’ ability to choose the most helpful treatment plan.
This trial tests a new gene therapy given directly into the brain tumor. It's for people with high-grade glioma, either newly diagnosed or after one recurrence, to see if it can help control the tumor.
This trial uses a special MRI scan to study the genetics of gliomas (a type of brain tumor). It may help doctors better understand your tumor and choose the right treatment. You can join if you have a suspected or confirmed low- or high-grade glioma that still has a measurable tumor after surgery.
Hear when a new Genetic Change trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.